(Q34294212)

1 August 2017

1 reference

title

Molecular regulation of lymphangiogenesis and targets for tissue oedema (English)

1 reference

1 August 2017

1 reference

Karkkainen MJ

1

1 reference

1 August 2017

Jussila L

2

1 reference

1 August 2017

Ferrell RE

3

1 reference

1 August 2017

Finegold DN

4

1 reference

1 August 2017

Alitalo K

5

1 reference

1 August 2017

publication date

1 January 2001

1 reference

Trends in Molecular Medicine

1 August 2017

published in

1 reference

1 August 2017

volume

7

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

18-22

1 reference

Cardiovascular failure in mouse embryos deficient in VEGF receptor-3

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Prox1 function is required for the development of the murine lymphatic system

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Mechanisms of angiogenesis and arteriogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Increased vascularization in mice overexpressing angiopoietin-1

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Angiopoietin-1 protects the adult vasculature against plasma leakage.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Hereditary lymphedema: evidence for linkage and genetic heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Mapping of primary congenital lymphedema to the 5q35.3 region

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Repeated unbalanced offspring due to a familial translocation involving chromosomes 5 and 6.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

A gene for lymphedema-distichiasis maps to 16q24.3.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Reduction of the genetic interval for lyphoedema-distichiasis to below 2 Mb.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cM interval on chromosome 15q

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

Lymphangioblasts in the avian wing bud

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2800%2901864-5

7 January 2021

10.1016/S1471-4914(00)01864-5

Identifiers

DOI

1 reference

release_fnojfy3b6vehbbhudcoojblk3i

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fnojfy3b6vehbbhudcoojblk3i

24 November 2022

mapped directly with Wikidata item

1 reference